Showing 11-20 of 73 results for "".
A Practical Approach: Field Treatment of AKs with PDT
https://practicaldermatology.com/issues/supplements/a-practical-approach-field-treatment-of-aks-with-pdt/20431/Why it's essential to treat visible and invisible actinic keratosis lesions and how PDT fits into the treatment armamentarium.Advantages of More Topical Gel
https://practicaldermatology.com/series/pdt-in-practice/advantages-of-more-topical-gel/29176/Dr. Ashish Bhatia discusses increased dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.Optimizing Patient Experience With Photodynamic Therapy
https://practicaldermatology.com/issues/supplements/optimizing-patient-experience-with-photodynamic-therapy/23972/As diagnoses of actinic keratosis rise, so has access to photodynamic therapy—making clear, compassionate communication a critical component of overall patient experience.AK Pearls: Managing Treatment Reactions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-pearls-managing-treatment-reactions/18741/Dr. Bhatia shares pearls for managing side effects and reactions to actinic keratosis treatment drugs. There are many adjunctive therapies to counter these reactions from emollients to barrier repair cream to time and some TLC for patients.Significant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.AK Treatment Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-treatment-pearls/19731/Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-New Analysis of Benzene Contamination in BPO Products
https://practicaldermatology.com/series/dermwire-tv/new-analysis-benzene-contamination-bpo-products/29074/In this week's DermwireTV, new data continues to raise concerns about benzene contamination in BPO products; the FDA expands the approved dosage for Ameluz for actinic keratosis (AK); and in our PA Perspectives segment, Andrew Mastro discusses how to approach a contract negotiation.Cutaneous Oncology in 2024
https://practicaldermatology.com/conferences/maui-derm-2024/cutaneous-oncology-in-2024/20266/Resident Of Distinction Award-winner Banu Farabi, MD, a PGY-3 resident at New York Medical College, talks about a review she attended highlighting the latest therapeutic approaches to treating conditions such as actinic keratosis and several different types of skin cancer, as well as an overview ofScientifically Speaking: Optimized Approaches to AK Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-optimized-approaches-to-ak-management/19912/What's new in AK therapy? From a new, first-in-class molecule to updated approaches with long-standing treatments, the management of actinic keratosis continues to evolve. Scientifically Speaking host Joel L. Cohen, MD speaks with Neal Bhatia, MD, Michael H. Gold, MD, and George Martin, MD about the- Almirall's Klisyri Gets FDA Approval for AKshttps://practicaldermatology.com/news/almiralls-klisyri-gets-fda-approval-for-aks/2460632/Almirall is expected to launch Klisyri® (tirbanibulin) for the topical treatment of actinic keratosis (AK) of the face or scalp in the first quarter of 2021, after receiving FDA approval this week. Klisyri® is a novel, topic